Proteomics is central to understanding biology, therapeutic mechanisms, and clinical responses. As the functional output of the genome, proteins govern cellular structure, signalling pathways, immune activity, and metabolism. High-quality proteomic data is therefore essential for biomarker discovery, translational research, and clinically relevant insight.
At Source Genomics, we provide advanced proteomic analysis to support clinical diagnostics and biopharmaceutical development. Our services deliver precise, reproducible protein measurements that enable meaningful interpretation of biological systems and disease processes.
Contact us to discuss your project today. Our team is committed to the highest quality standards and fast turnaround times, ensuring your research needs are always our top priority.
Proteomics Service Overview
Alamar Biosciences
We utilise next-generation proteomics from Alamar BioSciences, designed for the ultra-sensitive detection of proteins that are frequently below the limits of conventional assay technologies.
Alamar® Proteomics (ARGO™ HT System): High-throughput, ultra-sensitive protein analysis delivered through a fully automated, all-in-one platform. The ARGO HT System supports large-scale clinical and cohort studies, enabling streamlined workflows from sample to data or pooled NGS libraries within a single day, with an integrated qPCR readout.
This technology provides exceptional sensitivity, specificity, and reproducibility across a wide dynamic range, enabling confident detection of low-abundance, disease-relevant biomarkers that may be missed by traditional proteomic approaches, even in complex biological matrices.
Olink®
We employ advanced Proximity Extension Assay (PEA) technology to ensure accurate protein identification and quantification without the limitations of traditional mass spectrometry.
- Olink® Explore and Reveal: High-throughput profiling of up to 400+ proteins using Next-Generation Sequencing (NGS) readout, ideal for large-scale biomarker discovery.
- Olink® Target & Flex: Customisable and targeted panels for focused validation studies, utilising qPCR absolute and relative quantification.
These technologies enable high-sensitivity detection across broad dynamic ranges, allowing for the measurement of low-abundance biomarkers even in complex clinical matrices like plasma and serum.
Quantitative and Qualitative Protein Analysis
Our proteomics workflows are designed to deliver both depth and accuracy:
Biomarker Discovery:
Simultaneous measurement of hundreds of protein markers to identify signatures of disease, drug response, or toxicity.
Targeted Validation:
Precise quantification of specific protein panels to validate findings and support clinical utility.
Multi-Omic Integration:
Seamless integration of proteomic data with our genomic and transcriptomic services for a holistic view of biology.
All analyses are supported by rigorous data processing and expert scientific review to ensure results are biologically meaningful and clinically relevant.
Why Choose Source Genomics for Proteomics?
Partnering with Source Genomics provides access to a proteomics service built on scientific rigour, technical excellence, and quality assurance.
Advanced Analytical Instrumentation:
State-of-the-art Illumina NovaSeq, Olink, and Alamar Biosciences platforms deliver high sensitivity, resolution, and reproducibility.
Quality-Driven Laboratory Practice:
Proteomic testing is performed within ISO-accredited laboratories, supported by validated workflows and strict quality control processes to ensure data reliability and traceability.
Experienced Scientific Support:
Our specialists provide technical support throughout the project lifecycle from initial project consultations and panel selection to data interpretation and reporting.
Capabilities and Performance
Our proteomics services are designed to meet the demands of both clinical and biopharmaceutical applications:
High Sensitivity:
Detection of low-abundance proteins with exceptional specificity.
High Throughput Processing:
Scalable workflows capable of supporting large-scale clinical programmes.
Precision and Reproducibility:
Consistent data generation suitable for longitudinal studies and regulatory-aligned research.
Supporting Clinical and Translational Proteomics
Source Genomics integrates proteomics into broader molecular frameworks, enabling protein-level insights to complement genomic, transcriptomic, and spatial biology data. This integrated approach supports deeper biological understanding and more informed clinical decision-making.
Contact our scientific team to discuss your proteomics and wider research requirements, request a consultation, or obtain a detailed service proposal.